An IL-1 receptor antagonist blocks a morphine-induced attenuation of locomotor recovery after spinal cord injury

Brain, Behavior, and Immunity

Volumn 25, Issue 2, 2011, Pages 349-359

  Hook, Michelle A ^a   Washburn, Stephanie N ^a   Moreno, Georgina ^b   Woller, Sarah A ^a   Puga, Denise ^a   Lee, Kuan H ^a   Grau, James W ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Contusion; Cytokine; Inflammation; Neuropathic pain; Opioid

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MORPHINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONVALESCENCE; DRUG MECHANISM; LOCOMOTION; MALE; MOTOR PERFORMANCE; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; WEIGHT REDUCTION;

ANALGESICS, OPIOID; ANIMALS; AUTOPHAGY; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, SPINAL; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; INTERLEUKIN-6; LOCOMOTION; MALE; MORPHINE; MUSCLE SPASTICITY; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SENSATION; SPINAL CORD; SPINAL CORD INJURIES; URINARY BLADDER;

EID: 78651438612     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.10.018     Document Type: Article

References (56)

1. Basso D.M., Beattie M.S., Bresnahan J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 1995, 12:1-21.
2. Beattie M.S. Anatomic and behavioral outcome after spinal cord injury produced by a displacement controlled impact device. J. Neurotrauma 1992, 9:157-159. (discussion 159-160).
3. Beggs S., Salter M.W. Microglia-neuronal signaling in neuropathic pain hypersensitivity 2.0. Curr. Opin. Neurobiol. 2010, 20:474-480.
4. Behrmann D.L., Bresnahan J.C., Beattie M.S., Shah B.R. Spinal cord injury produced by consistent mechanical displacement of the cord in rats: behavioral and histologic analysis. J. Neurotrauma 1992, 9:197-217.
5. Christensen M.D., Hulsebosch C.E. Chronic central pain after spinal cord injury. J. Neurotrauma 1997, 14:517-537.
6. Constantini S., Young W. The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats. J. Neurosurg. 1994, 80:97-111.
7. Conti A., Miscusi M., Cardali S., Germano A., Suzuki H., Cuzzocrea S., Tomasello F. Nitric oxide in the injured spinal cord: synthases cross-talk, oxidative stress and inflammation. Brain Res. Rev. 2007, 54:205-218.
8. Coogan A.N., O'Neill L.A., O'Connor J.J. The P38 mitogen-activated protein kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1beta on long-term potentiation in the rat dentate gyrus in vitro. Neuroscience 1999, 93:57-69.
9. Crown E.D., King T.E., Meagher M.W., Grau J.W. Shock-induced hyperalgesia: III. Role of the bed nucleus of the stria terminalis and amygdaloid nuclei. Behav. Neurosci. 2000, 114:561-573.
10. Cui Y., Chen Y., Zhi J.L., Guo R.X., Feng J.Q., Chen P.X. Activation of p38 mitogen-activated protein kinase in spinal microglia mediates morphine antinociceptive tolerance. Brain Res. 2006, 1069:235-243.
11. Curran B.P., Murray H.J., O'Connor J.J. A role for c-Jun N-terminal kinase in the inhibition of long-term potentiation by interleukin-1beta and long-term depression in the rat dentate gyrus in vitro. Neuroscience 2003, 118:347-357.
12. Ferguson A.R., Hook M.A., Garcia G., Bresnahan J.C., Beattie M.S., Grau J.W. A simple post hoc transformation that improves the metric properties of the BBB scale for rats with moderate to severe spinal cord injury. J. Neurotrauma 2004, 21:1601-1613.
13. Grau J.W., Washburn S.N., Hook M.A., Ferguson A.R., Crown E.D., Garcia G., Bolding K.A., Miranda R.C. Uncontrollable stimulation undermines recovery after spinal cord injury. J. Neurotrauma 2004, 21:1795-1817.
14. Gruner J.A. A monitored contusion model of spinal cord injury in the rat. J. Neurotrauma 1992, 9:123-126. (discussion 126-8).
15. Gruol D.L., Nelson T.E. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol. Neurobiol. 1997, 15:307-339.
16. Gul H., Yildiz O., Dogrul A., Yesilyurt O., Isimer A. The interaction between IL-1beta and morphine: possible mechanism of the deficiency of morphine-induced analgesia in diabetic mice. Pain 2000, 89:39-45.
17. Hook M.A., Liu G.T., Washburn S.N., Ferguson A.R., Bopp A.C., Huie J.R., Grau J.W. The impact of morphine after a spinal cord injury. Behav. Brain Res. 2007, 179:281-293.
18. Hook M.A., Moreno G., Woller S., Puga D., Hoy K., Balden R., Grau J.W. Intrathecal morphine attenuates recovery of function after a spinal cord injury. J. Neurotrauma 2009, 26:741-752.
19. Horvath R.J., DeLeo J.A. Morphine enhances microglial migration through modulation of P2X4 receptor signaling. J. Neurosci. 2009, 29:998-1005.
20. Hutchinson M.R., Bland S.T., Johnson K.W., Rice K.C., Maier S.F., Watkins L.R. Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward. ScientificWorldJournal 2007, 7:98-111.
21. Hutchinson M.R., Coats B.D., Lewis S.S., Zhang Y., Sprunger D.B., Rezvani N., Baker E.M., Jekich B.M., Wieseler J.L., Somogyi A.A., Martin D., Poole S., Judd C.M., Maier S.F., Watkins L.R. Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia. Brain Behav. Immun. 2008, 22:1178-1189.
22. Hutchinson M.R., Zhang Y., Shridhar M., Evans J.H., Buchanan M.M., Zhao T.X., Slivka P.F., Coats B.D., Rezvani N., Wieseler J., Hughes T.S., Landgraf K.E., Chan S., Fong S., Phipps S., Falke J.J., Leinwand L.A., Maier S.F., Yin H., Rice K.C., Watkins L.R. Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav. Immun. 2010, 24:83-95.
23. Inoue A., Ikoma K., Morioka N., Kumagai K., Hashimoto T., Hide I., Nakata Y. Interleukin-1beta induces substance P release from primary afferent neurons through the cyclooxygenase-2 system. J. Neurochem. 1999, 73:2206-2213.
24. Johnston I.N., Milligan E.D., Wieseler-Frank J., Frank M.G., Zapata V., Campisi J., Langer S., Martin D., Green P., Fleshner M., Leinwand L., Maier S.F., Watkins L.R. A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J. Neurosci. 2004, 24:7353-7365.
25. King T.E., Joynes R.L., Meagher M.W., Grau J.W. Impact of shock on pain reactivity: II. Evidence for enhanced pain. J. Exp. Psychol. Anim. Behav. Process. 1996, 22:265-278.
26. Kigerl K.A., Lai W., Rivest S., Hart R.P., Satoskar A.R., Popovich P.G. Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J. Neurochem. 2007, 102:37-50.
27. Knoblach S.M., Fan L., Faden A.I. Early neuronal expression of tumor necrosis factor-alpha after experimental brain injury contributes to neurological impairment. J. Neuroimmunol. 1999, 95:115-125.
28. Liu S., Xu G.Y., Johnson K.M., Echetebu C., Ye Z.S., Hulsebosch C.E., McAdoo D.J. Regulation of interleukin-1beta by the interleukin-1 receptor antagonist in the glutamate-injured spinal cord: endogenous neuroprotection. Brain Res. 2008, 1231:63-74.
29. McLemore S., Crown E.D., Meagher M.W., Grau J.W. Shock-induced hyperalgesia: II. Role of the dorsolateral periaqueductal gray. Behav. Neurosci. 1999, 113:539-549.
30. McNaughton B.L. The mechanism of expression of long-term enhancement of hippocampal synapses: current issues and theoretical implications. Annu. Rev. Physiol. 1993, 55:375-396.
31. Merrill J.E., Benveniste E.N. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 1996, 19:331-338.
32. Murray C.A., Lynch M.A. Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age- and stress-induced impairments in long-term potentiation. J. Neurosci. 1998, 18:2974-2981.
33. Nakamura M., Houghtling R.A., MacArthur L., Bayer B.M., Bregman B.S. Differences in cytokine gene expression profile between acute and secondary injury in adult rat spinal cord. Exp. Neurol. 2003, 184:313-325.
34. Nesic O., Xu G.Y., McAdoo D., High K.W., Hulsebosch C., Perez-Pol R. IL-1 receptor antagonist prevents apoptosis and caspase-3 activation after spinal cord injury. J. Neurotrauma 2001, 18:947-956.
35. Pineau I., Lacroix S. Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J. Comp. Neurol. 2007, 500:267-285.
36. Prow N.A., Irani D.N. The inflammatory cytokine, interleukin-1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitis. J. Neurochem. 2008, 105:1276-1286.
37. Raghavendra V., Rutkowski M.D., DeLeo J.A. The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J. Neurosci. 2002, 22:9980-9989.
38. Reeve A.J., Patel S., Fox A., Walker K., Urban L. Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur. J. Pain 2000, 4:247-257.
39. Samad T.A., Moore K.A., Sapirstein A., Billet S., Allchorne A., Poole S., Bonventre J.V., Woolf C.J. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 2001, 410:471-475.
40. Schneider H., Pitossi F., Balschun D., Wagner A., del Rey A., Besedovsky H.O. A neuromodulatory role of interleukin-1beta in the hippocampus. Proc. Natl. Acad. Sci. USA 1998, 95:7778-7783.
41. Scholz J., Woolf C.J. The neuropathic pain triad: neurons, immune cells and glia. Nat. Neurosci. 2007, 10:1361-1368.
42. Shavit Y., Wolf G., Goshen I., Livshits D., Yirmiya R. Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance. Pain 2005, 115:50-59.
43. Song P., Zhao Z.Q. The involvement of glial cells in the development of morphine tolerance. Neurosci. Res. 2001, 39:281-286.
44. Stellwagen D., Beattie E.C., Seo J.Y., Malenka R.C. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J. Neurosci. 2005, 25:3219-3228.
45. Sung C.S., Wen Z.H., Chang W.K., Chan K.H., Ho S.T., Tsai S.K., Chang Y.C., Wong C.S. Inhibition of p38 mitogen-activated protein kinase attenuates interleukin-1beta-induced thermal hyperalgesia and inducible nitric oxide synthase expression in the spinal cord. J. Neurochem. 2005, 94:742-752.
46. Szabo I., Chen X.H., Xin L., Adler M.W., Howard O.M., Oppenheim J.J., Rogers T.J. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc. Natl. Acad. Sci. USA 2002, 99:10276-10281.
47. Tai Y.H., Wang Y.H., Wang J.J., Tao P.L., Tung C.S., Wong C.S. Amitriptyline suppresses neuroinflammation and up-regulates glutamate transporters in morphine-tolerant rats. Pain 2006, 124:77-86.
48. Trang T., Beggs S., Wan X., Salter M.W. P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J. Neurosci. 2009, 29:3518-3528.
49. Ulmann L., Hatcher J.P., Hughes J.P., Chaumont S., Green P.J., Conquet F., Buell G.N., Reeve A.J., Chessell I.P., Rassendren F. Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J. Neurosci. 2008, 28:11263-11268.
50. Viviani B., Bartesaghi S., Gardoni F., Vezzani A., Behrens M.M., Bartfai T., Binaglia M., Corsini E., Di Luca M., Galli C.L., Marinovich M. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci. 2003, 23:8692-8700.
51. Wang X.J., Kong K.M., Qi W.L., Ye W.L., Song P.S. Interleukin-1 beta induction of neuron apoptosis depends on p38 mitogen-activated protein kinase activity after spinal cord injury. Acta Pharmacol. Sin. 2005, 26:934-942.
52. Watkins L.R., Hutchinson M.R., Johnston I.N., Maier S.F. Glia: novel counter-regulators of opioid analgesia. Trends Neurosci. 2005, 28:661-669.
53. Watkins L.R., Hutchinson M.R., Ledeboer A., Wieseler-Frank J., Milligan E.D., Maier S.F. Glia as the " bad guys": implications for improving clinical pain control and the clinical utility of opioids. Brain Behav. Immun. 2007, 21:131-146. Norman Cousins Lecture.
54. Yang L., Blumbergs P.C., Jones N.R., Manavis J., Sarvestani G.T., Ghabriel M.N. Early expression and cellular localization of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in human traumatic spinal cord injury. Spine (Phila Pa 1976) 2004, 29:966-971.
55. Yang L., Jones N.R., Blumbergs P.C., Van Den Heuvel C., Moore E.J., Manavis J., Sarvestani G.T., Ghabriel M.N. Severity-dependent expression of pro-inflammatory cytokines in traumatic spinal cord injury in the rat. J. Clin. Neurosci. 2005, 12:276-284.
56. Zhang R.X., Li A., Liu B., Wang L., Ren K., Zhang H., Berman B.M., Lao L. IL-1ra alleviates inflammatory hyperalgesia through preventing phosphorylation of NMDA receptor NR-1 subunit in rats. Pain 2008, 135:232-239.